InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Saturday, 06/11/2022 9:32:55 AM

Saturday, June 11, 2022 9:32:55 AM

Post# of 16697
The so-called CEO is bent over a barrel (probably lovin' it) as shareholders fingers (digits) continue getting cut off (draining/diluting blood) to raise capital for a cash strapped company on the brink of bankruptcy. Moreau's past immoral acts have finally caught up with him at the worst time in the worst way for shareholders. It's obvious that his words and deeds have yet to carry the day in the eyes of would be newbie investors. It's a silly ass eight million dollar capital raise (in the grand scheme of things) and he's struggling to meet the mark/moment. Everything he touches becomes a long drawn out struggle. How anyone believes Christopher J. Moreau is a real CEO needs their head examined. I wouldn't put that guy in charge of a lemonade stand much less running a public company. My best guess is if long-winded Algernon Pharmaceuticals survives it will be shorted to no end. Sub $1 days are on the horizon. Hold onto your ass. The next cliff will be much steeper than the last.



https://algernonpharma.com/

M$